Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation

Abstract Backgrounds Non-valvular atrial fibrillation (AF) is the most common type of cardiac arrhythmia. AF is caused by electrophysiological abnormalities and alteration of atrial tissues, which leads to the generation of abnormal electrical impulses. Extracellular vesicles (EVs) are membrane-boun...

Full description

Bibliographic Details
Main Authors: Panjaree Siwaponanan, Pontawee Kaewkumdee, Wilasinee Phromawan, Suthipol Udompunturak, Nusara Chomanee, Kamol Udol, Kovit Pattanapanyasat, Rungroj Krittayaphong
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-021-03213-6
_version_ 1798033441589035008
author Panjaree Siwaponanan
Pontawee Kaewkumdee
Wilasinee Phromawan
Suthipol Udompunturak
Nusara Chomanee
Kamol Udol
Kovit Pattanapanyasat
Rungroj Krittayaphong
author_facet Panjaree Siwaponanan
Pontawee Kaewkumdee
Wilasinee Phromawan
Suthipol Udompunturak
Nusara Chomanee
Kamol Udol
Kovit Pattanapanyasat
Rungroj Krittayaphong
author_sort Panjaree Siwaponanan
collection DOAJ
description Abstract Backgrounds Non-valvular atrial fibrillation (AF) is the most common type of cardiac arrhythmia. AF is caused by electrophysiological abnormalities and alteration of atrial tissues, which leads to the generation of abnormal electrical impulses. Extracellular vesicles (EVs) are membrane-bound vesicles released by all cell types. Large EVs (lEVs) are secreted by the outward budding of the plasma membrane during cell activation or cell stress. lEVs are thought to act as vehicles for miRNAs to modulate cardiovascular function, and to be involved in the pathophysiology of cardiovascular diseases (CVDs), including AF. This study identified lEV-miRNAs that were differentially expressed between AF patients and non-AF controls. Methods lEVs were isolated by differential centrifugation and characterized by Nanoparticle Tracking Analysis (NTA), Transmission Electron Microscopy (TEM), flow cytometry and Western blot analysis. For the discovery phase, 12 AF patients and 12 non-AF controls were enrolled to determine lEV-miRNA profile using quantitative reverse transcription polymerase chain reaction array. The candidate miRNAs were confirmed their expression in a validation cohort using droplet digital PCR (30 AF, 30 controls). Bioinformatics analysis was used to predict their target genes and functional pathways. Results TEM, NTA and flow cytometry demonstrated that lEVs presented as cup shape vesicles with a size ranging from 100 to 1000 nm. AF patients had significantly higher levels of lEVs at the size of 101–200 nm than non-AF controls. Western blot analysis was used to confirm EV markers and showed the high level of cardiomyocyte expression (Caveolin-3) in lEVs from AF patients. Nineteen miRNAs were significantly higher (> twofold, p < 0.05) in AF patients compared to non-AF controls. Six highly expressed miRNAs (miR-106b-3p, miR-590-5p, miR-339-3p, miR-378-3p, miR-328-3p, and miR-532-3p) were selected to confirm their expression. Logistic regression analysis showed that increases in the levels of these 6 highly expressed miRNAs associated with AF. The possible functional roles of these lEV-miRNAs may involve in arrhythmogenesis, cell apoptosis, cell proliferation, oxygen hemostasis, and structural remodeling in AF. Conclusion Increased expression of six lEV-miRNAs reflects the pathophysiology of AF that may provide fundamental knowledge to develop the novel biomarkers for diagnosis or monitoring the patients with the high risk of AF.
first_indexed 2024-04-11T20:30:30Z
format Article
id doaj.art-895cbfabf95d41fd952c4a6e73429453
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-11T20:30:30Z
publishDate 2022-01-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-895cbfabf95d41fd952c4a6e734294532022-12-22T04:04:31ZengBMCJournal of Translational Medicine1479-58762022-01-0120111610.1186/s12967-021-03213-6Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillationPanjaree Siwaponanan0Pontawee Kaewkumdee1Wilasinee Phromawan2Suthipol Udompunturak3Nusara Chomanee4Kamol Udol5Kovit Pattanapanyasat6Rungroj Krittayaphong7Siriraj Center of Research Excellence for Microparticle and Exosome in Diseases, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Clinical Epidemiology, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDepartment of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDepartment of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol UniversitySiriraj Center of Research Excellence for Microparticle and Exosome in Diseases, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol UniversityAbstract Backgrounds Non-valvular atrial fibrillation (AF) is the most common type of cardiac arrhythmia. AF is caused by electrophysiological abnormalities and alteration of atrial tissues, which leads to the generation of abnormal electrical impulses. Extracellular vesicles (EVs) are membrane-bound vesicles released by all cell types. Large EVs (lEVs) are secreted by the outward budding of the plasma membrane during cell activation or cell stress. lEVs are thought to act as vehicles for miRNAs to modulate cardiovascular function, and to be involved in the pathophysiology of cardiovascular diseases (CVDs), including AF. This study identified lEV-miRNAs that were differentially expressed between AF patients and non-AF controls. Methods lEVs were isolated by differential centrifugation and characterized by Nanoparticle Tracking Analysis (NTA), Transmission Electron Microscopy (TEM), flow cytometry and Western blot analysis. For the discovery phase, 12 AF patients and 12 non-AF controls were enrolled to determine lEV-miRNA profile using quantitative reverse transcription polymerase chain reaction array. The candidate miRNAs were confirmed their expression in a validation cohort using droplet digital PCR (30 AF, 30 controls). Bioinformatics analysis was used to predict their target genes and functional pathways. Results TEM, NTA and flow cytometry demonstrated that lEVs presented as cup shape vesicles with a size ranging from 100 to 1000 nm. AF patients had significantly higher levels of lEVs at the size of 101–200 nm than non-AF controls. Western blot analysis was used to confirm EV markers and showed the high level of cardiomyocyte expression (Caveolin-3) in lEVs from AF patients. Nineteen miRNAs were significantly higher (> twofold, p < 0.05) in AF patients compared to non-AF controls. Six highly expressed miRNAs (miR-106b-3p, miR-590-5p, miR-339-3p, miR-378-3p, miR-328-3p, and miR-532-3p) were selected to confirm their expression. Logistic regression analysis showed that increases in the levels of these 6 highly expressed miRNAs associated with AF. The possible functional roles of these lEV-miRNAs may involve in arrhythmogenesis, cell apoptosis, cell proliferation, oxygen hemostasis, and structural remodeling in AF. Conclusion Increased expression of six lEV-miRNAs reflects the pathophysiology of AF that may provide fundamental knowledge to develop the novel biomarkers for diagnosis or monitoring the patients with the high risk of AF.https://doi.org/10.1186/s12967-021-03213-6Large extracellular vesiclesmiRNABiomarkersPatientsAtrial fibrillation
spellingShingle Panjaree Siwaponanan
Pontawee Kaewkumdee
Wilasinee Phromawan
Suthipol Udompunturak
Nusara Chomanee
Kamol Udol
Kovit Pattanapanyasat
Rungroj Krittayaphong
Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
Journal of Translational Medicine
Large extracellular vesicles
miRNA
Biomarkers
Patients
Atrial fibrillation
title Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
title_full Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
title_fullStr Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
title_full_unstemmed Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
title_short Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
title_sort increased expression of six large extracellular vesicle derived mirnas signature for nonvalvular atrial fibrillation
topic Large extracellular vesicles
miRNA
Biomarkers
Patients
Atrial fibrillation
url https://doi.org/10.1186/s12967-021-03213-6
work_keys_str_mv AT panjareesiwaponanan increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation
AT pontaweekaewkumdee increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation
AT wilasineephromawan increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation
AT suthipoludompunturak increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation
AT nusarachomanee increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation
AT kamoludol increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation
AT kovitpattanapanyasat increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation
AT rungrojkrittayaphong increasedexpressionofsixlargeextracellularvesiclederivedmirnassignaturefornonvalvularatrialfibrillation